Sialic Acid Storage Disease

This is a rare genetic disorder where a substance called sialic acid builds up in the body's cells. It affects the nervous system and can cause problems with movement, coordination, and bladder control. It usually starts in childhood.

Condition

What people with Sialic Acid Storage Disease report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Sialic Acid Storage Disease

What It Is

Sialic acid storage disease, now usually called free sialic acid storage disorder (FSASD), is a rare inherited condition that mainly affects the brain and spinal cord. Sialic acid is a sugar the body releases as it breaks down and recycles molecules inside cells. In FSASD it cannot leave the lysosomes, the compartments where that recycling happens, so it builds up over time. The result is slow or delayed development, intellectual disability and problems with muscle tone, balance and movement. The condition runs along a spectrum. In the mildest form, Salla disease, babies look healthy at birth, low muscle tone usually appears in the first year, and people often live into adulthood with a slowly progressive course. The severe form, infantile free sialic acid storage disease (ISSD), starts at or before birth and also affects the liver, spleen and heart; children with it usually survive only into early childhood. An intermediate form falls between the two. The name can cause confusion. Salla disease is sometimes called Finnish type sialuria, but French type sialuria is a different disorder: sialic acid is overproduced rather than trapped, it has a different genetic cause, and its features often ease with age.

Causes & Risk Factors

FSASD is caused by changes (variants) in a gene called SLC17A5, which carries the instructions for sialin, the protein that moves free sialic acid out of the lysosome. How much working sialin a person has largely shapes how severe the condition is. Nothing a parent did during pregnancy causes it, and there are no known environmental triggers. It is inherited in an autosomal recessive pattern: a child is affected only when they inherit a changed copy of the gene from each parent. Parents who each carry one copy are usually healthy. When both parents are carriers, each pregnancy has a 1 in 4 (25%) chance of an affected child. Salla disease is most common in people of Finnish and Swedish descent because of a variant shared in that population, but FSASD has been found in families worldwide.

How It's Diagnosed

Diagnosis often comes late, because early signs such as developmental delay, low muscle tone and unsteady movement have many possible causes. FSASD is worth considering in a child with global developmental delay, especially in speech, along with features such as coarse facial features, poor growth, an enlarged liver or spleen, or loss of skills over time. A urine test that measures free sialic acid is a useful clue, since levels are often many times higher than normal. It is not definitive: other conditions can raise it, and in some people with FSASD the result is normal or only slightly high. A brain MRI (magnetic resonance imaging) scan often shows delayed development of myelin (the insulating coating around nerve fibers) and a thin connection between the two halves of the brain, which supports the diagnosis. The diagnosis is confirmed by genetic testing that finds disease-causing variants in both copies of SLC17A5. Once a family's variants are known, relatives can have carrier testing, and testing during a future pregnancy or of embryos before implantation becomes possible.

Treatment Options

There is currently no approved treatment that slows or reverses FSASD. Care aims to manage each problem the condition causes and to help the person do as much as they can. Usually a team is involved, often including a neurologist, a metabolic or genetics specialist and rehabilitation therapists. In practice, that means standard seizure medicines when seizures occur, physical, occupational and speech therapy, and developmental and educational support. Feeding therapy and attention to nutrition help with poor growth, and calcium and vitamin D are used when bone density is low. Eye, heart and kidney problems are treated by the relevant specialists, and hernias are repaired when needed. Research is active but early. Approaches being studied in the lab include gene therapy and drugs that help a faulty sialin protein work better; none has yet been shown to help people with FSASD.

What to Expect

The outlook depends heavily on which form a person has. With Salla disease, development is delayed from infancy and abilities change slowly over years. Some children learn to walk and talk while others do not, and spasticity (stiff, tight muscles), unsteady balance and involuntary movements tend to increase with time. Intellectual disability means many people with Salla disease need ongoing support with daily life, and many live into adulthood. With the severe infantile form, children are seriously ill from early on, and care centers on feeding, growth, infections and other complications. Regular follow-up checks for problems that can build up quietly: seizures, growth and feeding, mobility, vision and hearing. Yearly eye exams are recommended for the intermediate and severe forms, and yearly heart tests and urine checks for protein help detect an enlarged heart or kidney involvement. Families often benefit from genetic counseling, social and respite support, and connection with other families through rare disease organizations.

When to Seek Help

Ask about an evaluation if a baby or child has low muscle tone, delayed milestones or loss of skills that has not been explained, particularly when there is a family history of FSASD. Arrange a review with the care team if seizures begin or change in pattern, feeding or weight gain becomes harder, or movement or vision seems to be worsening. For a child with the severe form, contact the care team promptly about breathing difficulty or signs of a chest infection, since respiratory infections can become life-threatening in that group.

Questions to Ask Your Doctor

  1. 1.Which form of FSASD does this appear to be, and what does that mean for the years ahead?
  2. 2.Which specialists and therapies should be part of care now, and how often will we review progress?
  3. 3.What signs should prompt us to contact you between visits?
  4. 4.Should other family members have carrier testing, and what are our options for a future pregnancy?
  5. 5.Are there research studies, registries or patient organizations we could join?

Last reviewed • Oct 2026

Educational content, not medical advice.